AKEBIA THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
AKEBIA THERAPEUTICS, INC. (AKBA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $13.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-05
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.00M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.40M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.20M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.50M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $13.00M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $14.40M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $11.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $13.50M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $13.50M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $13.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.70M 10-K · filed 2025-03-13 |
| 2024-09-30 | $8.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $9.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.20M 10-K · filed 2024-03-14 |
| 2015-12-31 | $9.70M 10-K · filed 2016-03-14 |
| 2014-12-31 | $8.65M 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |